Data / Form D filings / PD Theranostics, Inc.
PD Theranostics, Inc.: Form D filings
PD Theranostics, Inc., a biotechnology company in New York, NY, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on December 14, 2023, reports $150,000 sold of a $1 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 E 49TH STREET, 11TH FLOOR, New York, NY, 10017
- Phone
- (646) 335-5923
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1830286
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | New notice | $1,000,000 | $150,000 | $850,000 | 2 | Jul 12, 2022 | sec.gov |
| Jul 28, 2022 | Amendment | $5,940,000 | $358,165 | $5,581,835 | 3 | Jul 12, 2022 | sec.gov |
| Jul 28, 2022 | New notice | $5,940,000 | $358,165 | $5,581,835 | 3 | Jul 12, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Eitner | Director | |
| Patrick Gallagher | Executive Officer, Director | |
| James Ahern | Director | |
| Matthew Duffy | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 11, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PD Theranostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.